Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-12

FDA Approved: IRINOTECAN HYDROCHLORIDE 40 MG/2 ML — Supplemental Application (Armas Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for irinotecan hydrochloride 40 mg/2 mL from Armas Pharmaceuticals Inc., enabling its continued availability as a ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irinotecan Hydrochloride 40 mg/2 mL (irinotecan hydrochloride)

Snippet

SUPPL AP for IRINOTECAN HYDROCHLORIDE 40 MG/2 ML (IRINOTECAN HYDROCHLORIDE)